# AAV1-CMV-Serca2a GENe Therapy Trial in Heart Failure

> **NCT01966887** · PHASE2 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 10 (actual)

## Conditions studied

- Heart Failure Congestive
- Ischemic Cardiomyopathy
- Non-ischemic Cardiomyopathy

## Interventions

- **GENETIC:** MYDICAR-single intracoronary infusion
- **GENETIC:** Placebo; single intracoronary infusion

## Key facts

- **NCT ID:** NCT01966887
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2015-09
- **Final completion:** 2016-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01966887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01966887, "AAV1-CMV-Serca2a GENe Therapy Trial in Heart Failure". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01966887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*